MedTrace Logo

Chronic Intestinal Pathologies Analytical Cohort at TouLouse

NCT04896684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-06-28

No results posted yet for this study

Summary

In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.

Conditions

Interventions

BIOLOGICAL

blood and intestinal biopsy sampling

24 mL of blood and 10 intestinal biopsies will be sampled

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Barbara Bournet, MD, PhD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04896684 on ClinicalTrials.gov